Dauntless Pharmaceuticals Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Series A1
  • Latest Deal Amount
  • $25M
Latest Deal Amount
  • Investors
  • 2

Dauntless Pharmaceuticals General Information

Description

Developer of specialty therapeutics designed to offer a non-injectable somatostatin analog alternative. The company's therapeutics include inhibitors of growth hormone that are administered solely by injecting in approved products and is used as first-line pharmacotherapy for two orphan diseases, acromegaly and neuroendocrine tumors, enabling patients with a non-invasive alternative to benefit from short-acting therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 9920 Pacific Heights Boulevard
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dauntless Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A1) 09-Feb-2018 $25M 0000 Completed Clinical Trials - General
1. Early Stage VC (Series A) 21-Jul-2015 0000 0000 Completed Startup
To view Dauntless Pharmaceuticals’s complete valuation and funding history, request access »

Dauntless Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of specialty therapeutics designed to offer a non-injectable somatostatin analog alternative. The company's th
Drug Discovery
San Diego, CA
2 As of 2020
0000
00000000000 0000

000 0000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000 000000000
Carmel, IN
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00000000

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dauntless Pharmaceuticals Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MBX Biosciences Venture Capital-Backed Carmel, IN 00 000.00 00000000000 000.00
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
00000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 Corporation Buena Vista, CO 0 0000000000
You’re viewing 5 of 31 competitors. Get the full list »

Dauntless Pharmaceuticals Patents

Dauntless Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200353419-A1 Membrane emulsification device for microsphere creation Pending 22-Nov-2017 0000000000
US-20200281857-A1 Therapeutic compound formulations Pending 22-Nov-2017 0000000000
EP-3713545-A1 Therapeutic compound formulations Withdrawn 22-Nov-2017 0000000000
EP-3713660-A1 Membrane emulsification device for microsphere creation Withdrawn 22-Nov-2017 0000000000
EP-3630059-A1 Peptide compositions and methods of use Pending 26-May-2017 A61K9/0043

Dauntless Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Michelle Mazzoni Ph.D Vice President, Regulatory Affairs and Quality
Joel Martin Ph.D Co-Founder, Board Member, President & Chief Executive Officer
You’re viewing 2 of 4 executive team members. Get the full list »

Dauntless Pharmaceuticals Board Members (5)

Name Representing Role Since
David Kabakoff Ph.D Sofinnova Investments Board Member 000 0000
Ellen Lubman Self Board Member 000 0000
Joel Martin Ph.D Self Co-Founder, Board Member, President & Chief Executive Officer 000 0000
Michael Powell Ph.D Sofinnova Investments Chairman 000 0000
Nina Kjellson Canaan Partners Board Member 000 0000
To view Dauntless Pharmaceuticals’s complete board members history, request access »

Dauntless Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dauntless Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Canaan Partners Venture Capital Minority 000 0000 000000 0
Sofinnova Investments Venture Capital Minority 000 0000 000000 0
To view Dauntless Pharmaceuticals’s complete investors history, request access »